Categories
Research Insights
FDA: Efficient and Innovative Natural History Studies Addressing Unmet Needs in Rare Diseases
This funding opportunity supports prospective or retrospective, efficient, and innovative natural history studies with a focus on collaborative and standardized approaches to ensure data quality and interpretability.
Amount: $1,600,000 (Prospective Studies); $300,000 (Retrospective Studies)
Due Date: 01/09/2026 (LOI); 02/10/2026 (Full Proposal)